Sebastian Schönherr - Epidemiology

Author Information

Sebastian Schönherr is affiliated with the Institute of Genetic Epidemiology at the Medical University of Innsbruck in Innsbruck, Austria. His work focuses on the genetic epidemiology of various diseases, including cardiovascular disease, chronic kidney disease, and infectious diseases such as SARS-CoV-2.

Research Contributions

Sebastian Schönherr has made substantial contributions to the field of genetic epidemiology. His research encompasses a broad range of topics, including the genetic factors influencing hyperlipoprotein(a)emia, stroke, and chronic kidney disease. He has also contributed to the understanding of mitochondrial DNA variations and their association with metabolic syndrome and type 2 diabetes. Additionally, his work on the persistence of immunity to SARS-CoV-2 and the genetic predisposition to various diseases highlights his diverse research interests. His efforts in expanding variant calling pipelines for clinical research further showcase his expertise in genomic methodologies.

Aliases

Sebastian Schönherr is also known by the following aliases:

S. Schönherr S Schöherr

Publication and Citation Metrics

Metric	Value
Total Papers	77
Total Citations	6213
h-index	22

Publications:

Genome-Wide Characterization of a Highly Penetrant Form of Hyperlipoprotein(a)emia Associated With Genetically Elevated Cardiovascular Risk

DOI: 10.1161/CIRCGEN.121.003489

Year: 2022

A Family and a Genome-Wide Polygenic Risk Score Are Independently Associated With Stroke in a Population-Based Study.

DOI: 10.1161/STROKEAHA.121.036551

Year: 2022

Apolipoprotein A‐IV concentrations and clinical outcomes in a large chronic kidney disease cohort: Results from the GCKD study

DOI: 10.1111/joim.13437

Year: 2021

From Forensics to Clinical Research: Expanding the Variant Calling Pipeline for the Precision ID mtDNA Whole Genome Panel

DOI: 10.3390/ijms222112031

Year: 2021

Analyzing Low-Level mtDNA Heteroplasmy—Pitfalls and Challenges from Bench to Benchmarking

DOI: 10.3390/ijms22020935

Year: 2021

Apolipoprotein A-IV concentrations and clinical outcomes in chronic kidney disease patients: Results from the German Chronic Kidney Disease (GCKD) study

DOI: 10.1016/j.atherosclerosis.2021.06.490

Year: 2021

A high-resolution HLA reference panel capturing global population diversity enables multi-ancestry fine-mapping in HIV host response

DOI: 10.1038/s41588-021-00935-7

Year: 2021

Persistence of immunity to SARS-CoV-2 over time in the ski resort Ischgl

DOI: 10.1016/j.ebiom.2021.103534

Year: 2021

Association of mitochondrial DNA copy number with metabolic syndrome and type 2 diabetes in 14 176 individuals

DOI: 10.1111/joim.13242

Year: 2021

Lipoprotein(a) and SARS‐CoV‐2 infections: susceptibility to infections, ischemic heart disease and thromboembolic events

DOI: 10.1111/joim.13338

Year: 2021

What Are the Health Implications of Tapeworm Infections?

Why Are Prognostic Factors Important?

How Important is Communication in Incident Response?

How are Respiratory Issues Diagnosed?

How is Screening Implemented?

Why are Patient Demographics Important in Epidemiology?

How Does Histone Modification Impact Health?

What Are The Challenges in Studying Diet and Disease?

What are the Key Strategies for Cancer Prevention?

How Can Advances in Technology Aid Pharmacological Epidemiology?

Partnered Content Networks

Relevant Topics